Risk factors for poor tuberculosis treatment outcome in Finland: A cohort study

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Vasankari, Tuula ^a,b   Holmström, Pekka ^a   Ollgren, Jukka ^a   Liippo, Kari ^b   Kokki, Maarit ^a   Ruutu, Petri ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; CHILD; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; FINLAND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; INFANT; INTERNAL MEDICINE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NEWBORN; PREDICTOR VARIABLE; RISK FACTOR; SEX DIFFERENCE; STRESS; TREATMENT OUTCOME; TUBERCULOSIS; UNIVARIATE ANALYSIS; HEALTH SURVEY; INCIDENCE; LUNG TUBERCULOSIS; MEDICAL AUDIT; METHODOLOGY; MIDDLE AGED; MIGRATION; MORTALITY; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; STANDARD;

ADULT; AGED; COHORT STUDIES; EMIGRANTS AND IMMIGRANTS; FEMALE; FINLAND; HUMANS; INCIDENCE; MALE; MEDICAL AUDIT; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PUBLIC HEALTH ADMINISTRATION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 36649038368     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-291     Document Type: Article

References (35)

1. Tuberculosis elimination in the countries of Europe and other industrialized countries. L Clancy HL Rieder DA Enarson S Spinaci, Eur Respir J 1991 4 1288 1295 1804678
2. WHO Tuberculosis Programme: framework for effective tuberculosis control. World Health Organization, World Health Organization Document WHO/TB/94.179 World Health Organization, Geneva 1994
3. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. JF Broekmans GB Migliori HL Rieder J Lees P Ruutu R Loddenkemper MC Raviglione World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group, Eur Respir J 2002 19 4 765 775 10.1183/09031936.02.00261402 11999007
4. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working group of the World Health organisation (WHO) and the European Region of the International Union against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. J Veen M Raviglione HL Rieder GB Migliori P Graf M Grzemska R Zalesky, Eur Respir J 1998 12 505 510 10.1183/09031936.98.12020505 9727811
5. Revised international definitions in tuberculosis control. WHO, IUATLD, and KNCV, Int J Tuberc Lung Dis 2001 5 3 213 215 11326818
6. Classification of treatment outcomes. EuroTB, WHO Euro/EuroTB joint data collection - CISID 2001
7. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. JP Zellweger P Coulon, Int J Tuberc Lung Dis 1998 2 5 372 377 9613632
8. Outcome of pulmonary tuberculosis treatment in the tertiary care setting -Toronto 1992/93. W Wobeser L Yuan M Naus the Tuberculosis Treatment Completion Study Group, CMAJ: Canadian Medical Association Journal 1999 160 6 789 794 10189422
9. Progress and problems in achieving the United States national target for completion of antituberculosis treatment. DP Chin KC Cummings S Sciortino DC Snyder LF Johnson JL Westenhouse SE Royce, Int J Tuberc Lung Dis 2000 4 8 744 751 10949326
10. Evaluation of tuberculosis treatment results in Italy, report 1998. Tuberculosis section of the National AIPO Study Group on Infectious Disease and the SMIRA Group. R Centis A Ianni GB Migliori, Monaldi Arch Chest Dis 2000 55 4 293 298 11057082
11. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000. LP Ormerod N Horsfield RM Green, Int J Tuberc Lung Dis 2002 6 8 662 665 12150476
12. Current status of treatment completion and fatality among tuberculosis patients in Spain. JA Cayla JA Caminero R Rey N Lara X Valles H Galdos-Tanguis Working Group on Completion of Tuberculosis Treatment in Spain, Int J Tuberc Lung Di 2004 8 4 458 464
13. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2004. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region, Institut de veille sanitaire, Saint-Maurice, France 2006
14. Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992. T Lillebaek S Poulsen A Kok-Jensen, Int J Tuberc Lung Dis 1999 3 7 603 612 10423223
15. Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country? L Trnka D Daòkova F Krejbich, Int J Tuberc Lung Dis 2001 5 3 250 256 11326824
16. Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. P Helbling C Medinger E Altpeter PA Raeber D Beeli JP Zellweger, Swiss Med Wkly 2002 132 35-36 517 522 12506334
17. The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998. LP Ormerod RJ Prescott, Clin Med 2003 3 1 57 61 12617417
18. Tuberculosis treatment outcomes in Europe: a systematic review. A Faustini AJ Hall CA Perucci, Eur Respir J 2005 26 503 510 10.1183/09031936.05. 00103504 16135735
19. The fate of cases of pulmonary tuberculosis under various treatment programmes. S Grzybowski DA Enarson, Bull Int Union Tuberc 1978 53 70 75 737353
20. Great diversity of tuberculosis treatment in Finland. T Vasankari M Kokki P Holmström K Liippo S Sarna P Ruutu, Euro Surveill 2007 12 1 [Epub ahead of print]: PMID: 17370977 17370977
21. Treatment outcome of new culture positive pulmonary tuberculosis in Norway. M Farah A Tverdall T Steen E Heldall A Brantsaeter G Bjune, BMC Public Health 2005 5 14 15698472 10.1186/1471-2458-5-14
22. Exploring the determinants of treatment success for tuberculosis cases in Europe. D Falzon Y Le Strat F Belghiti A Infuso EuroTB Correspondents, Int J Tuberc Lung Dis 2005 9 1224 1229 16333929
23. Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group, Scand J Haematol 1979 23 119 123 386480
24. Is volume related to outcome in health care? A systematic review and methodological critique of the literature. EA Halm C Lee MR Chassin, Ann Intern Med 2002 137 511 520 12230353
25. The association between hospital volume and survival after acute myocardial infarction in elderly patients. DR Thiemann J Coresh WJ Oetgen NR Powe, N Engl J Med 1999 340 1640 1648 10.1056/NEJM199905273402106 10341277
26. High sensivity for tuberculosis in a laboratory-based national integrated infectious disease surveillance system in Finland. M Kokki P Holmström P Ruutu, Euro Surveill 2005 10 90 93 16077215
27. Tuberkuloosi ja sen lääkehoito. Lääkintö hallitus, Finnish National Board of Health Tuberculosis and its treatment. Kapseli 15. Lääkintöhallituksen julkaisu 1985. (in Finnish)
28. Guidelines for tuberculosis treatment in adults and children in National Tuberculosis Programmes. World Health Organization Tuberculosis Unit, Division of Communicable Disease, WHO/TB/91, 161
29. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society, Am Rev Resp Dis 1986 134 355 363 3527010
30. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations. Joint Tuberculosis Committee of the British Thoracic Society, Thorax 1990 45 403 408 2382247
31. Clinical tuberculosis. PDO Davies, London, MacMillan Education 1994
32. Tuberkuloosin lääkehoito ja -profylaksia. Tuberculosis treatment and prophylaxis. E Tala, Duodecim 1993 109 69 75 (in Finnish) 8013311
33. Analysis of tuberculosis deaths in Finland from 1974 to 1993. T Vasankari, Thesis. Turku University Series D 1998 304
34. Rising case fatality of bacteriologically proven pulmonary tuberculosis in the Netherlands. G de Meer HA van Geuns, Tuberc Lung Dis 1992 73 83 86 10.1016/0962-8479(92)90060-W
35. Tuberculosis in London -the importance of homelessness, problem drug use and prison. A Story S Murad M Verheyen W Roberts AC Hayward, Thorax 2007 62 8 667 71 10.1136/thx.2006.065409 17289861